Endovia Health Sciences sets interim CEO, COO pay at $300,000 and $275,000 with market-cap bonuses up to $300,000
EDVA•Interim CEO and COO compensation terms
Endovia Health Sciences entered employment agreements on Aug. 20, 2026 with interim CEO Brady Cobb and interim COO Michael Bondurant.
- Cobb's base salary was set at $300,000; Bondurant's at $275,000.
- Each can earn $50,000 if market cap rises $5 million by Oct. 30, 2026, and another $50,000 if it reaches $10 million by Dec. 31.
- An additional bonus equals 3% of market-cap gains above the $10 million threshold in 2026, capped at $300,000.
- Cobb received 231,250 options; Bondurant received 200,000.
- Shareholder-approved RSUs are tied to 7% of a 20% fully diluted share pool.
